Conditional approval for plan to organize drugmaker into new company with board appointed by public officials
A US federal bankruptcy judge on Wednesday conditionally approved a sweeping, potentially $10bn plan submitted by the OxyContin maker Purdue Pharma to settle a mountain of lawsuits over its role in the opioid crisis that has killed a half-million Americans over the past two decades.
Related: Former Purdue Pharma chair denies responsibility for US opioid crisis
Continue reading...from US news | The Guardian https://ift.tt/1Zwv3jN
